mechanism 2,636 words KG: ent-dise-93f3d65f
Contents

Mitochondrial Dysfunction in ALS-FTD Spectrum

Mechanism Info
Nameent-dise-93f3d65f

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (35)

Microbial Inflammasome Priming Prevention
Score: 0.65
Cryptic Exon Silencing Restoration
Score: 0.53
Cross-Seeding Prevention Strategy
Score: 0.69
Glycine-Rich Domain Competitive Inhibition
Score: 0.64
Metabolic Switch Targeting for A1→A2 Repolarization
Score: 0.73
Mitochondrial-Nuclear Epigenetic Cross-Talk Restoration
Score: 0.70
Perforant Path Presynaptic Terminal Protection Strategy
Score: 0.70
Metabolic Reprogramming via Coordinated Multi-Gene CRISPR Ci
Score: 0.60
Digital Twin-Guided Metabolic Reprogramming
Score: 0.55
Metabolic Reprogramming via Microglial Glycolysis Inhibition
Score: 0.67
APOE-Dependent Autophagy Restoration
Score: 0.89
AMPK hypersensitivity in astrocytes creates enhanced mitocho
Score: 0.83
Senescent Cell Mitochondrial DNA Release
Score: 0.74
Near-infrared light therapy stimulates COX4-dependent mitoch
Score: 0.74
TFAM overexpression creates mitochondrial donor-recipient gr
Score: 0.73
Mitochondrial Transfer Pathway Enhancement
Score: 0.70
CX43 hemichannel engineering enables size-selective mitochon
Score: 0.69
RAB27A-dependent extracellular vesicle engineering for mitoc
Score: 0.67
Mitochondrial-Lysosomal Contact Site Engineering
Score: 0.67
GAP43-mediated tunneling nanotube stabilization enhances neu
Score: 0.67
pg 1/2Next →

Related Analyses (30)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD AD
neurodegeneration · archived
How do non-cell autonomous effects of autophagy dysfunction
neurodegeneration · completed

Related Experiments (26)

FTD Microglia Role: Protective vs Destructive Mechanism Stud
validation · proposed · Score: 0.40
Progranulin Replacement Therapy for FTD — Vector Development
clinical · proposed · Score: 0.40
Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT
validation · proposed · Score: 0.40
Cytochrome Therapeutics
clinical · proposed · Score: 0.40
C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study
clinical · proposed · Score: 0.40

Knowledge Graph (12 edges)

33300249 increased in ent-dise-93f3d65f
30458231 could be beneficial in ent-dise-93f3d65f
39317854 increase risk of ent-dise-93f3d65f
39317854 associated with increased risk of ent-dise-93f3d65f
35767949 are selectively vulnerable in ent-dise-93f3d65f
34663413 is altered in ent-dise-93f3d65f
41752118 is increasingly seen as ent-dise-93f3d65f
34873335 causes ent-dise-93f3d65f
24369373 has an oligogenic basis with ent-dise-93f3d65f
24369373 are broadening the phenotype associated with ent-dise-93f3d65f

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.